Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$154.67 - $290.89 $3.29 Million - $6.2 Million
21,299 New
21,299 $3.4 Million
Q1 2022

May 16, 2022

SELL
$194.8 - $275.7 $5.88 Million - $8.32 Million
-30,172 Closed
0 $0
Q4 2021

Nov 08, 2023

BUY
$255.32 - $318.29 $7.7 Million - $9.6 Million
30,172 New
30,172 $8.03 Million
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $7.7 Million - $9.6 Million
30,172 New
30,172 $8.03 Million
Q4 2018

Feb 13, 2019

SELL
$73.27 - $105.19 $642,211 - $921,990
-8,765 Closed
0 $0
Q3 2018

Nov 08, 2023

BUY
$81.43 - $108.13 $713,733 - $947,759
8,765 New
8,765 $928,000
Q3 2018

Nov 14, 2018

BUY
$81.43 - $108.13 $713,733 - $947,759
8,765 New
8,765 $929,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.